Surgeon vs. Non-Surgical Orthopedic Doctor in Glastonbury, CT

In most cases, start with a non-surgical specialist. A thorough non-surgical evaluation, including live ultrasound, does not close off surgery as an option. It simply makes sure surgery gets recommended only when it is genuinely necessary, not by default. If non-surgical treatment will not help, or imaging shows a structural problem it cannot fix, Dr. Tortland will say so directly and refer you to a trusted orthopedic surgeon. A surgeon's first opinion comes from someone trained primarily to operate; a non-surgical specialist's first opinion gives you an unbiased read on whether you need surgery at all before you commit to that path.

Every new patient receives a comprehensive evaluation, including a live musculoskeletal ultrasound exam in the same visit. Dr. Tortland assesses joint space, alignment, and tissue condition alongside your symptoms and goals to determine whether PRP is likely to provide meaningful benefit.

PRP is prepared through custom laboratory processing rather than a single fixed protocol. Baseline blood counts are measured for each patient, unwanted red and white blood cells are minimized, and platelets are concentrated to 12 to 15 times baseline levels, then delivered under direct ultrasound guidance. PRP concentration varies significantly by preparation method, and most patients aren't aware of this difference before treatment.

Yes. Dr. Tortland is focused on getting each patient the best outcome, not on performing a specific procedure. When evaluation and imaging show that surgery is the more appropriate path, he explains why clearly and refers the patient to a trusted orthopedic surgeon.

Not exactly, and the distinction matters. Dr. Tortland performs bone marrow aspirate (BMA) and microfragmented adipose tissue (MFAT) procedures that are same-day and autologous (your own tissue), containing a mix of cell types including adult progenitor cells. This is different from cultured or expanded "stem cell" products some clinics market, which are not FDA-approved and carry more regulatory and safety uncertainty. Dr. Tortland only uses same-day, minimally manipulated autologous tissue.

Timelines vary by patient and by what's being treated. Most patients notice gradual improvement between 6 and 16 weeks as inflammation settles and tissue responds, and improvement can continue for up to a year; response isn't guaranteed for everyone. Dr. Tortland sets expectations at your evaluation based on your specific diagnosis and imaging, not a generic timeline.

Because BMA and MFAT use your own tissue, processed same-day and not cultured or expanded, the risk profile is favorable. Most patients experience only mild, short-term soreness at the collection and injection sites. As with any procedure, it isn't right for every patient or every diagnosis; candidacy is determined by exam and live ultrasound, not assumed from a phone call.